Intraductal Papillary Mucinous Neoplasm With Malignant Change

Terminated

• Conditions: IPMN

• Registration Number: NCT02044926
• Lead Sponsor: Asan Medical Center

Brief Summary

Purpose:

To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012.

Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.

Detailed Description

1. Purpose

* To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012

2. Enroll criteria

* Patient who is suspected to have pancreas IPMN on imaging

* Interval between imaging study and surgery is less than 2 months

* Who is scheduled for surgery due to IPMN

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2014-01-21
• Study First Submitted QC: 2014-01-23
• Study First Posted: 2014-01-24
• Primary Completion: 2016-05
• Status Verified: 2016-07
• Study Completion: 2016-07
• Last Update Submitted: 2016-07-20
• Last Update Posted: 2016-07-22

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

• Patients who is suspected to have IPMN by imaging study or clinician
• Time interval between imaging study and surgery less than 2 months

Exclusion Criteria

• Patients who have pathology results not by surgery
• Who is less than 20 years old
• Who cannot voluntarily agree study design

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Imaging predictor of malignant IPMN of the pancreas	one month	We will assess baseline CT and MRI findings of patients within one month after surgery.

Trial Locations

Locations (1)

Asan Medical Center; 🇰🇷 Seoul, Korea, Republic of